{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:43:15Z","timestamp":1772822595567,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2024KQNCX197"],"award-info":[{"award-number":["2024KQNCX197"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073722"],"award-info":[{"award-number":["82073722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130101"],"award-info":[{"award-number":["82130101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010495"],"award-info":[{"award-number":["2025A1515010495"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118058","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:34:02Z","timestamp":1754980442000},"page":"118058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery and optimization of OA amide derivatives containing a trisubstituted  -hydroxyproline fragment as novel Omicron fusion inhibitors"],"prefix":"10.1016","volume":"299","author":[{"given":"Chongjun","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongjiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-1337","authenticated-orcid":false,"given":"Gaopeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118058_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118058_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118058_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1359380","article-title":"The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China","volume":"15","author":"Liao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118058_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118058_bib5","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118058_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1248\/bpb.b23-00639","article-title":"Current status and perspectives of therapeutic antibodies targeting the spike protein S2 subunit against SARS-CoV-2","volume":"47","author":"Yamamoto","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2025.118058_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105655","article-title":"Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection","volume":"216","author":"Milan Bonotto","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118058_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cmi.2022.04.018","article-title":"Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2025.118058_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118058_bib10","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.apsb.2023.07.007","article-title":"Azvudine reduces the in-hospital mortality of COVID-19 patients: a retrospective cohort study","volume":"13","author":"Zong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118058_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc2214302","article-title":"Efficacy of antiviral agents against omicron subvariants BQ.1.1 and XBB","volume":"388","author":"Imai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118058_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Molnupiravir and Nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118058_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 Omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118058_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011231","article-title":"Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir","volume":"19","author":"Torii","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.118058_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118058_bib16","article-title":"SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation","volume":"119","author":"Yu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.118058_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118058_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118058_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","article-title":"The glycosylation in SARS-CoV-2 and its receptor ACE2","volume":"6","author":"Gong","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118058_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41392-023-01472-x","article-title":"Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines","volume":"8","author":"Guo","year":"2023","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.ejmech.2025.118058_bib21","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118058_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112703118","article-title":"Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein","volume":"118","author":"Tai","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.118058_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118058_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-020-00325-1","article-title":"Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118058_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/v14030489","article-title":"The analogs of furanyl methylidene rhodanine exhibit broadspectrum. inhibitory and inactivating activities against enveloped viruses, including SARS-CoV-2 and its variants","volume":"14","author":"Pu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.118058_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41422-022-00617-x","article-title":"Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant","volume":"32","author":"Xia","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118058_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-021-00712-2","article-title":"Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation","volume":"6","author":"Xia","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118058_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac198","article-title":"Targeting an evolutionarily conserved \"E-L-L\" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2","volume":"1","author":"Jana","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ejmech.2025.118058_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8408","article-title":"Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes","volume":"4","author":"Si","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118058_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejmech.2016.04.061","article-title":"Structure-activity relationships of 3-O-\u03b2-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors","volume":"119","author":"Song","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-021-00628-x","article-title":"Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118058_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105985","article-title":"Synthesis and structure-activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2","volume":"127","author":"Jang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113242","article-title":"Discovery and structural optimization of 3-O-\u03b2-chacotriosyl oleananetype triterpenoids as potent entry inhibitors of SARS-CoV-2 virus infections","volume":"215","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114426","article-title":"Identification, optimization, and biological evaluation of 3-O-\u03b2-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein","volume":"238","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115463","article-title":"Optimization, and biological evaluation of 3-O-\u03b2-chacotriosyl betulinic acid amide derivatives as novel small-molecule Omicron","volume":"256","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib36","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.1021\/acs.jmedchem.3c01144","article-title":"VHL-modified proteolysis targeting chimeras (PROTACs) as a strategy to evade metabolic degradation in in vitro applications","volume":"66","author":"Castellani","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118058_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14756366.2017.1422125","article-title":"Synthesis, biological activity and molecular modelling studies of shikimic acid derivatives as inhibitors of the shikimate dehydrogenase enzyme of Escherichia coli","volume":"33","author":"D\u00edaz-Quiroz","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:02:07Z","timestamp":1772802127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S0223523425008232"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118058","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and optimization of OA amide derivatives containing a trisubstituted l-hydroxyproline fragment as novel Omicron fusion inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118058"}}